AzTrials
AzTrials

Hearing Loss, BilateralPhase 2NCT07205484

Long-Term Outcomes of Early Communication Intervention for Deaf/Hard of Hearing Toddlers

A Phase 2 study testing Parent-Mediated Intervention (PMI) in people with Hearing Loss, Bilateral, run by Northwestern University at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The overall goal of this randomized clinical trial is to learn about the effects of a parent-mediated intervention (PMI) designed to support communication outcomes for deaf and hard-of-hearing (DHH) children. Previously, the investigators enrolled 96 DHH children between 12 and 18 months of age and their parents. Read more about this study

Who is it for?
Ages 5 to 8 years
Conditions the study is for
Hearing Loss, Bilateral
What is being tested?
Parent-Mediated Intervention (PMI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 siteUnited States
Study dates
12 Aug 2025to Mar 2030
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Eligibility for the follow-up period of the clinical trial is dependent on enrollment in the initial period of the clinical trial.

Child inclusion criteria were:

  • between 12-18 months
  • diagnosed with bilateral hearing loss
  • no additional diagnoses (e.g., Down syndrome, cerebral palsy, seizure disorder, blindness, etc.)
  • one parent with typical hearing
  • exposed to some degree of spoken language by their parents.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Northwestern University

    Evanston, Illinois, 60202

Other trials in United States

About this study

Official title: Early Communication Intervention for Deaf/Hard of Hearing Toddlers: Long-Term Language and Literacy Outcomes

The overall goal of this randomized clinical trial is to learn about the effects of a parent-mediated intervention (PMI) designed to support communication outcomes for deaf and hard-of-hearing (DHH) children. Previously, the investigators enrolled 96 DHH children between 12 and 18 months of age and their parents. Families were randomly assigned to receive either the PMI or a business-as-usual control group. The PMI was a 6-month intervention that included weekly, hour-long Zoom sessions. During the intervention sessions, parents were taught communication support strategies to support their child's language development throughout daily routines and play.

This current period of the trial follows the same children into early elementary school to determine whether the effects of the PMI are long-lasting. The main questions it aims to answer are:

Read more
  • Does the PMI improve language, reading, and social communication outcomes in the early school years?
  • Does parent involvement during early intervention support continued engagement in their child's education?

The investigators will compare parents and children who received the PMI to those in the business-as-usual control group to determine whether the intervention has lasting effects on these outcomes.

Participants will complete standardized assessments, parent-report surveys, and video-recorded naturalistic interactions. All assessments will be completed remotely.

Read the detailed description

Hearing loss is one of the most prevalent congenital conditions. Recent advances in early detection and technology have contributed to significant improvements in long-term outcomes for deaf/hard-of-hearing (DHH) children. Despite this progress, language and literacy outcomes for school-age DHH children are inconsistent, and many DHH children do not "catch up" to their hearing peers. Closing this gap requires the implementation of effective early communication interventions. Yet, until recently, there was a significant paucity of research on early communication interventions for DHH children. Parent-mediated interventions (PMIs), which involve teaching parents strategies to enhance their child's language learning experiences, are a promising form of early intervention for DHH toddlers. During the previous project period (NCT03803943), 96 DHH children, between 12 and 18 months of age and their parents, were enrolled. Parent-child dyads were randomly assigned to receive either the PMI or business-as-usual control group. The investigators examined the effects of the intervention on (a) parent strategy use and (b) child communication outcomes during and after the 6-month intervention period. The follow-up period of the clinical trial is outlined here.

This trial will be the first large-scale evaluation of the long-term effects of an early communication intervention on school-age language and literacy outcomes for DHH children. The study enrolled 96 parent-child dyads, 88 of whom remain involved and consented to contact for the follow-up period. The investigators will complete follow-up assessments during early elementary school. The investigators plan to examine the long-term effects of the intervention on school-age outcomes and characterize the intermediary mechanisms of these effects. The investigators consider not only how early communication interventions affect subsequent child outcomes, but also how involving parents early in their child's development may lay the foundation for sustained parent engagement as children transition to school-based services. Taken together, the investigators plan to integrate child and parent outcomes to fully characterize how early language learning experiences shape long-term language and literacy outcomes. Understanding the pathways through which early interventions affect the developmental trajectory of DHH children will have widespread implications for research and clinical practice.

Being tested
Parent-Mediated Intervention (PMI)
Keywords
Hearing Loss, School-Aged Outcomes, Language, Literacy, Early Intervention, Parent-Mediated Intervention
Medical subject headings
Hearing Loss, Bilateral, Hearing Loss, Language, Literacy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parent-Mediated Intervention (PMI)Behavioural

    Also called Parent-Implemented Communication Intervention (PICT), Parent-Implemented Communication Treatment (PICT)

    The PMI consisted of weekly, 1-hour intervention sessions via Zoom for 6 months. In total, the intervention consisted of 26 intervention sessions.

Study groups in NCT07205484
Study groupRoleWhat they receive
Parent-Mediated Intervention (PMI)ExperimentalParticipants in both the parent-mediated intervention (PMI) group and the business-as-usual (BAU) control group continued to receive standard community-based early intervention services outside of the clinical trial. In addition to these services, dyads in the PMI group participated in weekly intervention sessions via Zoom for 6 months. Intervention sessions followed a Teach-Model-Coach-Review framework to support parents in using communication support strategies with their child. Parents were taught seven communication support strategies in a fixed sequence: (1) Setting the Stage, (2) Play and Engage, (3) Respond and Wait, (4) Notice and Say, (5) Show It, (6) Contrast It, and (7) Add On. These strategies focused on helping parents create opportunities for language learning during everyday routines and play, notice and respond to their child's communication, and model rich, salient language.
Receives: Behavioral: Parent-Mediated Intervention (PMI)
Business-As-Usual (BAU) ControlNo interventionParticipants in both the parent-mediated intervention (PMI) group and the business-as-usual (BAU) control group continued to receive standard community-based early intervention services outside of the clinical trial. Dyads in the BAU control group did not receive the PMI.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Evaluation of Language Fundamentals, Fifth Edition (CELF-5)

    The Clinical Evaluation of Language Fundamentals, Fifth Edition (CELF-5) is a standardized assessment of language development. The Core Language Standard Score (M = 100, SD = 15) reflects the child's global language ability, with higher scores indicating better language skills.

    Measured: 7 - 8 years old

  2. Peer-Peer Interaction, Pragmatic Observational Measure (POM)

    The Pragmatic Observational Measure (POM), a rating scale of pragmatic skills, will be scored during a naturalistic peer-peer interaction. The POM includes 27 items, capturing a range of pragmatic skills, rated on a 4-point scale (1 = rarely or never observed; 4 = almost always observed). The POM Total Raw Score (Min = 27, Max = 108) reflects the child's pragmatic skills, with higher scores indicating better pragmatic skills.

    Measured: 7 - 8 years old

  3. Woodcock Reading Mastery Tests, Third Edition (WRMT-III)

    The Woodcock Reading Mastery Tests, Third Edition (WRMT-III) is a standardized assessment of reading development. The Total Reading Cluster Standard Score (M = 100, SD = 15) reflects the child's global reading ability, with higher scores indicating better reading skills.

    Measured: 7 - 8 years old

Secondary outcomes (5)
  1. Parent-Child Interaction, Keys to Interactive Parenting Scale (KIPS)

    The Keys to Interactive Parenting Scale (KIPS), a rating scale of parenting behaviors, will be scored during a naturalistic parent-child interaction.The KIPS includes 12 items, capturing a range of parenting behaviors, rated on a 5-point scale, with higher scores reflecting higher quality parent behaviors. The KIPS Total Mean Score (Min = 1.0, Max = 5.0), calculated as the average of all 12 items, reflects the overall quality of parenting behaviors.

    Measured: 5 - 6 years old

  2. Parent Empowerment and Efficacy Measure (PEEM)

    The Parent Empowerment and Efficacy Measure (PEEM) is a self-report questionnaire assessing parents' confidence in their role and their ability to support their child's development. The measure includes 20 items rated on a 10-point scale (1 = no agreement; 10 = complete agreement). The PEEM Total Raw Score (Min = 20, Max = 200) reflects overall parenting self-efficacy, with higher scores indicating greater self-efficacy.

    Measured: 5 - 6 years old

  3. Parental Involvement Survey in Their Child's Elementary Studies (PISCES)

    The Parental Involvement Survey in Their Child's Elementary Studies (PISCES) is a parent-report questionnaire that assesses parent involvement in school-related activities. The measure includes 56 items rated on a 4-point Likert scale (1 = strongly disagree; 4 = strongly agree). The PISCES Total Raw Score (Min = 56, Max = 224) reflects the extent of parent involvement in their child's education, with higher scores indicating greater involvement.

    Measured: 5 - 6 years old

  4. The Parent Advocacy Skills and Comfort Survey

    The Parent Advocacy Skills and Comfort Survey is a parent-report questionnaire assessing caregivers' ability to advocate for their child's educational needs. The survey includes 10 items rated on a 5-point Likert scale (1 = strongly disagree; 5 = strongly agree). The Total Raw Score (Min = 10, Max = 50) reflects overall advocacy skills and confidence, with higher scores indicating greater advocacy skills and confidence.

    Measured: 5 - 6 years old

  5. Clinical Evaluation of Language Fundamentals, Fifth Edition (CELF-5)

    The Clinical Evaluation of Language Fundamentals, Fifth Edition (CELF-5) is a standardized assessment of language development. The Core Language Standard Score (M = 100, SD = 15) reflects the child's global language ability, with higher scores indicating better language skills.

    Measured: 5 - 6 years old

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start12 Aug 2025
  3. Primary completionMar 2030 (estimated)
  4. Study completionMar 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parent-child dyads were randomly assigned to the parent-mediated intervention (PMI) or business-as-usual (BAU) control group. Randomization was stratified on hearing device and communication mode. Hearing device was dichotomized as either (1) hearing aid or (2) cochlear implant, cochlear implant candidate, or bone conduction device. Communication mode was dichotomized as using visual communication with the child (1) less than 10% of the time or (2) 10% or more of the time.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
88 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07205484
Sponsor's protocol ID
2R01DC016877-06A1
Status last verified
May 2026
First submitted
6 Aug 2025
Last updated
1 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All participant-level data related to the primary and secondary outcomes of the clinical trial will be preserved and shared via Dryad. All shared data will be de-identified by using a unique study identifier and age in months rather than date of birth. This will allow for the replication of all analyses for the primary aims and for other investigators to answer other questions that are not related to the study aims. The final results of the study will be uploaded to clinicaltrials.gov. All data as described above will be shared, as allowed by informed consents. The only data that will not be shared are the video recordings of the observational peer-peer and parent-child interactions, which contain participants' faces.

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Parent-Mediated Intervention (PMI) in people with Hearing Loss, Bilateral, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 1 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Evaluation of Language Fundamentals, Fifth Edition (CELF-5) (time frame: 7 - 8 years old). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in